Radium chloride

Preparation

Radium chloride crystallises from aqueous solution as the dihydrate. The dihydrate is dehydrated by heating to 100 °C in air for one hour followed by 5.5 hours at 520 °C under argon. If the presence of other anions is suspected, the dehydration may be effectuated by fusion under hydrogen chloride.

Radium chloride can also be prepared by heating radium bromide in a flow of dry hydrogen chloride gas. It can be produced by treating radium carbonate with hydrochloric acid.

Properties

Radium chloride is a colorless salt with a blue-green luminescence, especially when heated. Its color gradually changes to yellow with aging, whereas contamination by barium may impart a rose tint. It is less soluble in water than other alkaline earth metal chlorides – at 25 °C its solubility is 245 g/L whereas that of barium chloride is 307 g/L, and the difference is even larger in hydrochloric acid solutions. This property is used in the first stages of the separation of radium from barium by fractional crystallization. Radium chloride is only sparingly soluble in azeotropic hydrochloric acid and virtually insoluble in concentrated hydrochloric acid.

Gaseous shows strong absorptions in the visible spectrum at 676.3 nm and 649.8 nm (red): the dissociation energy of the radium–chlorine bond is estimated as 2.9 eV, and its length as 292 pm.

Contrary to diamagnetic barium chloride, radium chloride is weakly paramagnetic with a magnetic susceptibility of 1.05. Its flame color is red.

Uses

Radium chloride is still used for the initial stages of the separation of radium from barium during the extraction of radium from pitchblende. The large quantities of material involved (to extract a gram of pure radium metal, about 7 tonnes of pitchblende is required) favour this less costly (but less efficient) method over those based on radium bromide or radium chromate (used for the later stages of the separation).

It was also used in medicine to produce radon gas which in turn was used as a brachytheraputic cancer treatment.

Radium-223 dichloride (USP, radium chloride Ra 223), tradename Xofigo (formerly Alpharadin), is an alpha-emitting radiopharmaceutical. Bayer received FDA approval for this drug to treat prostate cancer osteoblastic bone metastases in May 2013. Radium-223 chloride is one of the most potent ((antineoplastic drugs)) known. One dose (50 kBq/kg) in an adult is about 60 nanograms; this amount is 1/1000 the weight of an eyelash (75 micrograms).

References

Bibliography

• Gmelins Handbuch der anorganischen Chemie (8. Aufl.), Berlin:Verlag Chemie, 1928, pp. 60–61.

References

1. (5 September 1910). "RADIOACTIVITÉ. Sur le radium métallique. Note de Mme P. CURIE et M. A. DEBIERNE". [[C. R. Hebd. Séances Acad. Sci.]].
2. (1968). "Crystal Chemistry of Radium. I. Radium Halides". Radiochimica Acta.
3. (1934). "Revision des Atomgewichtes des Radiums". Zeitschrift für anorganische und allgemeine Chemie.
4. (1930). "Löslichkeits-Bestimmungen einiger Radiumsalze". Berichte der Deutschen Chemischen Gesellschaft (A and B Series).
5. Lagerqvist, A. (1953). ''Arkiv Fisik'' '''6''':141–42.
6. Karapet'yants, M. Kh.; Ch'ing, Ling-T'ing (1960). ''Zh. Strukt. Khim.'' '''1''':277–85; ''J. Struct. Chem. (USSR)'' '''1''':255–63.
7. (1975). "Radon seed implants. Residual radioactivity after 33 years". Archives of Dermatology.
8. Winston, P.. (June 1958). "Carcinoma of the Trachea Treated by Radon Seed Implantation". The Journal of Laryngology & Otology.
9. (December 1964). "The Radiochemistry of Radium". Subcommittee on Radiochemistry, [[National Academies of Sciences, Engineering, and Medicine#National Research Council.